Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Apr-24 5:19 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 15-Apr-24 | Option Exercise | 19,818 | $81.21 | $1,609,430.00 | 49% 40.78K to 60.6K | (6%) |
| 17-Apr-24 5:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-Apr-24 | Planned Private Option Sale | 19,818 | $133.37 | $2,643,020.00 | (33%) 60.6K to 40.78K | |
| 15-Mar-24 5:33 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-Mar-24 | Option Exercise | 75,000 | $80.90 | $6,067,630.00 | 184% 40.78K to 115.78K | (6%) |
| 15-Mar-24 5:33 PM View: | Neurocrine Biosciences Inc. (NBIX) | 14-Mar-24 | Planned Private Option Sale | 75,000 | $139.38 | $10,453,400.00 | (65%) 115.78K to 40.78K | |
| 29-Feb-24 6:55 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Feb-24 | Option Exercise | 75,000 | $53.67 | $4,025,040.00 | 185% 40.62K to 115.62K | |
| 29-Feb-24 6:55 PM View: | Neurocrine Biosciences Inc. (NBIX) | 28-Feb-24 | Planned Option Sale | 75,000 | $134.69 | $10,101,600.00 | (65%) 115.62K to 40.62K | |
| 15-Feb-24 5:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,098 | $133.01 | $146,050.00 | (3%) 41.71K to 40.62K | |
| 08-Feb-24 7:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 980 | $134.19 | $131,509.00 | (2%) 40.61K to 39.63K | |
| 08-Feb-24 7:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 1,280 | $142.12 | $181,910.00 | (3%) 40.03K to 38.75K | |
| 02-Feb-24 7:05 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 1,207 | $140.78 | $169,927.00 | (3%) 38.81K to 37.6K | |
| 23-Aug-23 7:59 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 1,600 | $107.40 | $171,836.00 | (4%) 38.04K to 36.44K | |
| 08-Feb-23 7:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 980 | $104.12 | $102,036.00 | (3%) 35.36K to 34.38K | |
| 08-Feb-23 7:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 17,390 | $102.41 | $1,780,870.00 | (34%) 50.89K to 33.5K | |
| 08-Feb-23 7:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 1,280 | $105.63 | $135,201.00 | (7%) 19.16K to 17.88K | |
| 02-Feb-23 5:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,207 | $109.95 | $132,710.00 | (7%) 17.94K to 16.73K | |
| 10-Jan-23 5:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Jan-23 | Option Exercise | 400 | $43.24 | $17,296.00 | 3% 15.64K to 16.04K | |
| 10-Jan-23 5:13 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Jan-23 | Planned Option Sale | 400 | $125.00 | $50,000.00 | (2%) 16.04K to 15.64K | |
| 01-Dec-22 6:43 PM View: | Neurocrine Biosciences Inc. (NBIX) | 30-Nov-22 | Option Exercise | 50,000 | $41.47 | $2,073,270.00 | 320% 15.64K to 65.64K | |
| 01-Dec-22 6:43 PM View: | Neurocrine Biosciences Inc. (NBIX) | 30-Nov-22 | Planned Option Sale | 50,000 | $125.90 | $6,295,080.00 | (76%) 65.64K to 15.64K | |
| 10-Nov-22 5:50 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Nov-22 | Option Exercise | 100 | $41.78 | $4,178.00 | < 1% 15.64K to 15.74K | |
| 10-Nov-22 5:50 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Nov-22 | Planned Option Sale | 100 | $125.36 | $12,536.20 | (< 1%) 15.74K to 15.64K | |
| 10-Nov-22 5:50 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Nov-22 | Option Exercise | 24,593 | $41.78 | $1,027,500.00 | 157% 15.64K to 40.24K | |
| 10-Nov-22 5:50 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Nov-22 | Planned Option Sale | 24,593 | $125.33 | $3,082,320.00 | (61%) 40.24K to 15.64K | |
| 04-Nov-22 4:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Nov-22 | Option Exercise | 8,968 | $41.78 | $374,683.00 | 57% 15.64K to 24.61K | |
| 04-Nov-22 4:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Nov-22 | Planned Option Sale | 8,968 | $125.02 | $1,121,180.00 | (36%) 24.61K to 15.64K | |
| 04-Nov-22 4:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-22 | Option Exercise | 400 | $41.78 | $16,712.00 | 3% 15.64K to 16.04K | |
| 04-Nov-22 4:56 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-22 | Planned Option Sale | 400 | $125.00 | $50,000.00 | (2%) 16.04K to 15.64K | |
| 19-Oct-22 5:55 PM View: | Neurocrine Biosciences Inc. (NBIX) | 17-Oct-22 | Private Sale (Planned) | 4,960 | $110.82 | $549,682.00 | (24%) 20.6K to 15.64K | |
| 09-Feb-22 6:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 980 | $79.67 | $78,072.60 | (5%) 21.32K to 20.34K | |
| 09-Feb-22 6:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 4,119 | $80.78 | $332,748.00 | (17%) 23.58K to 19.46K | |
| 18-Aug-21 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 16-Aug-21 | Market Sale (Planned) | 5,628 | $89.62 | $504,395.00 | (27%) 21.24K to 15.61K | (2%) |
| 09-Feb-21 9:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 4,270 | $116.82 | $498,842.00 | (17%) 25.37K to 21.1K | 1% |
| 09-Feb-21 9:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-21 | Market Sale (Planned) | 809 | $114.03 | $92,247.00 | (5%) 17.24K to 16.43K | (1%) |
| 27-Jan-21 8:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 26-Jan-21 | Option Exercise | 300 | $41.78 | $12,534.00 | 2% 15.8K to 16.11K | |
| 27-Jan-21 8:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 26-Jan-21 | Market Sale (Planned) | 400 | $120.00 | $48,000.00 | (2%) 16.11K to 15.71K | 4% |
| 27-Jan-21 8:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Option Exercise | 3,477 | $41.78 | $145,269.00 | 20% 17.41K to 20.88K | |
| 27-Jan-21 8:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Market Option Sale (Planned) | 3,777 | $120.03 | $453,338.00 | (18%) 20.88K to 17.11K | 4% |
| 27-Jan-21 8:58 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Market Sale (Planned) | 1,300 | $120.03 | $156,034.00 | (8%) 17.11K to 15.8K | 4% |
| 16-Nov-20 6:27 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.71 | $204,723.00 | (11%) 19.66K to 17.41K | (27%) |
| 04-Nov-20 6:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-20 | Option Exercise | 20,595 | $35.99 | $741,214.00 | 134% 15.37K to 35.97K | |
| 04-Nov-20 6:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-20 | Market Option Sale (Planned) | 20,595 | $96.53 | $1,987,970.00 | (57%) 35.97K to 15.37K | (20%) |
| 07-Aug-20 6:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.85 | $268,254.00 | (13%) 17.63K to 15.37K | 3% |
| 28-Apr-20 8:33 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.45 | $192,338.00 | (13%) 15.28K to 13.34K | (16%) |
| 17-Apr-20 9:48 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-Apr-20 | Market Sale (Planned) | 8,632 | $94.65 | $817,018.00 | (43%) 20.23K to 11.6K | (22%) |
| 11-Feb-20 7:08 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 2,030 | $103.32 | $209,747.00 | (9%) 22.12K to 20.09K | (12%) |
| 07-Feb-20 6:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-20 | Market Sale (Planned) | 1,395 | $101.48 | $141,561.00 | (7%) 19.66K to 18.26K | (14%) |
| 07-Feb-20 6:35 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-20 | Market Sale (Planned) | 1,954 | $103.03 | $201,311.00 | (10%) 18.96K to 17.01K | (12%) |
| 17-Jul-19 7:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 15-Jul-19 | Market Sale (Planned) | 5,835 | $87.44 | $510,201.00 | (28%) 20.75K to 14.91K | (32%) |
| 08-Feb-19 5:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-19 | Market Sale (Planned) | 920 | $83.57 | $76,883.00 | (4%) 21.66K to 20.75K | (38%) |
| 06-Feb-19 5:59 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Feb-19 | Market Sale (Planned) | 1,357 | $88.01 | $119,427.00 | (7%) 20.37K to 19.02K | (31%) |